Vitamin D and Child Neurodevelopment-A Post Hoc Analysis.

Area of Science:

• Pediatric Health
• Neuroscience
• Nutritional Science

Background:

• Vitamin D (VitD) plays a role in neurodevelopment, but its precise impact remains debated.
• Higher 25-hydroxy-vitamin D (25(OH)D) levels are often associated with improved neurodevelopmental outcomes.
• Conflicting data necessitates further investigation into the relationship between vitamin D status and child neurodevelopment.

Purpose of the Study:

• To examine the association between maternal vitamin D supplementation doses and offspring neurodevelopmental outcomes in 3-5-year-old children.
• To investigate the relationship between circulating 25(OH)D concentrations and neurodevelopmental performance.
• To explore the influence of vitamin D binding protein (VDBP) genotype on neurodevelopmental trajectories.

Main Methods:

• Pregnant women were randomized to receive 400, 2000, or 4000 IU/day of vitamin D3.
• Offspring underwent neurodevelopmental assessment using the Brigance Screen at 3-5 years of age.
• Measurements included 25(OH)D concentrations at birth and 3-5 years, alongside VDBP genotyping.

Main Results:

• Elevated 25(OH)D levels at assessment correlated with better overall neurodevelopmental scores (Brigance quotient).
• Children of mothers receiving 2000 IU/day showed improved language scores compared to the standard dose group.
• Specific VDBP genotypes (Gc1f-1s, Gc1f-2) were associated with higher academic scores and lower language scores.

Conclusions:

• Higher early-life 25(OH)D concentrations and increased maternal vitamin D intake during pregnancy may positively impact neurodevelopment.
• The VDBP genotype appears to be a significant factor in neurodevelopment, influencing different developmental domains distinctly.